GO:0045446 endothelial cell differentiation: Developmental Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045446 endothelial cell differentiation is the biological process by which mesodermal, bone marrow, or neural crest cells acquire the specialized features of endothelial cells, the thin flattened cells that line body cavities, blood vessels, and lymph vessels [1, 7].
• The process is driven by a conserved transcriptional hierarchy involving ETV2, FLI1, TAL1, LMO2, and GATA2, which establish the hemogenic endothelium and endothelial progenitor programs [1, 7].
• Signaling inputs from VEGF-A, Notch, TGF-beta/BMP, and Piezo1 mechanotransduction coordinate endothelial specification, sprouting, and arterial-venous identity [4, 5, 7].
• Endothelial cell differentiation is essential for embryonic vascular development, and its dysregulation contributes to cardiovascular disease, tumor angiogenesis, and vascular malformations [5, 7].
• Human pluripotent stem cells and induced pluripotent stem cells can be differentiated into endothelial cells, providing tractable in vitro models for disease modeling and drug discovery [3, 8].
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal interrogation of endothelial differentiation genes in vitro and in vivo [1, 5].
Description
Endothelial cells form the inner lining of blood and lymphatic vessels and are essential for vascular homeostasis, nutrient exchange, and immune cell trafficking [1, 7]. The generation of these cells from precursor populations is governed by the biological process annotated as GO:0045446, endothelial cell differentiation. This process encompasses the molecular and cellular events through which mesodermal, bone marrow, or neural crest cells acquire the specialized features of endothelial cells, including a thin flattened morphology and the capacity to form a continuous monolayer [1, 7]. Understanding endothelial cell differentiation is therefore central to developmental biology, vascular medicine, and regenerative strategies aimed at restoring or inhibiting blood vessel growth [5, 7]. Research over the past two decades has defined a core transcriptional network that drives endothelial specification, with ETV2 acting as a master regulator upstream of FLI1, TAL1, LMO2, and GATA2 [1, 7]. These factors cooperate with signaling pathways such as VEGF-A, Notch, BMP/TGF-beta, and mechanosensitive Piezo1 to pattern arterial, venous, and lymphatic endothelial identities [4, 5, 7]. In parallel, advances in pluripotent stem cell differentiation have made it possible to generate human endothelial cells in vitro for disease modeling and therapeutic screening [3, 8]. For researchers, GO:0045446 provides a structured framework to interpret transcriptomic, proteomic, and functional screens focused on vascular development. Because endothelial dysfunction underlies diverse pathologies, from atherosclerosis to tumor angiogenesis, tools that precisely manipulate endothelial differentiation genes, such as CRISPR knockout and knock-in models, are increasingly important for causal inference [1, 5, 7].
endothelial cell differentiation At A Glance
| GO ID | GO:0045446 |
|---|---|
| GO term | endothelial cell differentiation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Acquisition of endothelial cell identity from mesodermal, bone marrow, or neural crest precursors |
| Definition source | QuickGO definition |
| Related processes | Hemogenic specification, vasculogenesis, angiogenesis, endothelial-to-mesenchymal transition |
| Key regulators | ETV2, FLI1, TAL1, LMO2, GATA2, VEGF-A, Notch, Piezo1 |
| Research models | hPSC/iPSC differentiation, zebrafish, mouse embryos, CRISPR-engineered cell lines |
What Is GO:0045446?
GO:0045446, endothelial cell differentiation, is the biological process in which a mesodermal, bone marrow, or neural crest cell acquires the specialized features of an endothelial cell, a thin flattened cell. A layer of such cells lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium [1, 7]. This definition captures both the developmental origin of endothelial cells and their characteristic morphology and anatomical distribution.
Why Is endothelial cell differentiation Important in Cell Biology?
Endothelial cell differentiation is fundamental to the formation and maintenance of the vascular system, which supplies oxygen and nutrients to every tissue and serves as a conduit for immune surveillance [1, 7]. Defects in this process cause embryonic lethality in model organisms and contribute to human cardiovascular diseases, including aberrant angiogenesis, vascular malformations, and impaired endothelial repair [5, 7]. Moreover, the ability to direct endothelial differentiation from pluripotent stem cells holds promise for cell-based therapies, tissue engineering, and drug discovery [3, 8]. Because endothelial cells also participate in organ-specific niches, such as the liver macrophage niche, understanding their differentiation informs broader questions in immunology and regenerative medicine.
• Endothelial cell differentiation is required for embryonic vascular development and blood vessel formation [1, 7].
• Dysregulated endothelial differentiation contributes to cardiovascular diseases such as atherosclerosis and pathological angiogenesis [5, 7].
• Endothelial cells influence organ-specific immune niches, including Kupffer cell identity in the liver.
• Human pluripotent stem cell-derived endothelial cells enable disease modeling and regenerative medicine applications [3, 8].
• Endothelial Piezo1 mechanotransduction promotes vascular smooth muscle cell differentiation on large arteries, linking endothelial differentiation to vessel maturation.
• Endothelial cell-released mitochondrial DNA can promote B cell differentiation during viral infection, illustrating crosstalk with immune cells.
• CRISPR screens in endothelial differentiation models can identify novel regulators of vascular development [1, 5].
• Endothelial differentiation is a key step in tumor angiogenesis, making it a target for anti-angiogenic therapy [5, 7].
• In vitro differentiation protocols from iPSCs provide scalable sources of endothelial cells for high-throughput screening [3, 8].
• Understanding endothelial differentiation informs efforts to engineer vascularized tissues and organs [1, 7].
What Happens During endothelial cell differentiation?
Specification of mesodermal precursors
In simple terms: Early embryonic cells receive signals that instruct them to become endothelial progenitors.
Endothelial cell differentiation begins with the specification of mesodermal precursors toward a hemogenic or angiogenic fate. This step is marked by the induction of ETV2, a master transcriptional regulator that initiates the endothelial program [1, 7]. ETV2 expression is followed by activation of downstream factors such as FLI1, TAL1, LMO2, and GATA2, which together establish endothelial progenitor identity [1, 7]. Signaling through BMP and TGF-beta pathways contributes to mesodermal patterning and endothelial specification [5, 7].
Hemogenic endothelium and endothelial progenitor formation
In simple terms: Some endothelial precursors first generate blood cells before becoming mature endothelial cells.
A subset of endothelial progenitors forms hemogenic endothelium, a specialized intermediate that gives rise to hematopoietic cells while retaining endothelial potential. This process is tightly regulated by the same transcriptional network that drives endothelial differentiation, including RUNX1 and its cofactors. The hemogenic endothelium is a transient population that subsequently transitions into committed endothelial cells, a step essential for both blood and vessel formation [1, 7].
Acquisition of endothelial morphology and markers
In simple terms: Precursor cells change shape and start displaying proteins typical of endothelial cells.
As differentiation proceeds, cells acquire the characteristic thin, flattened morphology of endothelial cells and express hallmark surface markers such as CD31 (PECAM1), VE-cadherin (CDH5), and VEGFR2 (KDR) [1, 7]. These markers are used experimentally to identify and isolate endothelial cells from differentiating cultures [3, 8]. The acquisition of a monolayer-forming capacity and barrier function reflects the specialized features defined by GO:0045446 [1, 7].
Arterial-venous and lymphatic specification
In simple terms: Endothelial cells become specialized into artery, vein, or lymphatic types.
Following initial differentiation, endothelial cells acquire arterial, venous, or lymphatic identities guided by signaling pathways such as VEGF-A, Notch, and COUP-TFII [5, 7]. Arterial specification depends on Notch activation and Hey/Hes gene expression, while venous identity is promoted by COUP-TFII. Lymphatic specification requires PROX1 and SOX18 [5, 7]. This heterogeneity is critical for matching endothelial function to the needs of different vascular beds.
Mechanotransduction and vessel maturation
In simple terms: Physical forces from blood flow help endothelial cells mature and stabilize vessels.
Mechanical forces exerted by blood flow are sensed by endothelial cells through mechanosensitive channels such as Piezo1, which promotes vascular smooth muscle cell differentiation and vessel maturation on large arteries. This mechanotransduction pathway links endothelial differentiation to the structural integrity of the vessel wall. In vitro, shear stress can be applied to endothelial monolayers to study these maturation processes [4, 8].
Key Genes Involved in GO:0045446 endothelial cell differentiation
The following genes and proteins are central to endothelial cell differentiation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ETV2 | Master transcriptional regulator of endothelial specification | Knockout causes loss of endothelial and hematopoietic lineages; key target for differentiation studies [1, 7] |
| FLI1 | Ets-family transcription factor cooperating with ETV2 | Regulates endothelial gene expression; knockout impairs vascular development [1, 7] |
| TAL1 | Transcription factor in hemogenic endothelium | Required for hematopoietic and endothelial programs; studied in differentiation models |
| LMO2 | Transcriptional cofactor in endothelial and hematopoietic development | Forms complexes with TAL1 and GATA2; knockout leads to vascular defects [1, 7] |
| GATA2 | Transcription factor in hemogenic endothelium | Regulates endothelial and hematopoietic gene programs [1, 7] |
| KDR (VEGFR2) | Receptor for VEGF-A signaling | Essential for endothelial differentiation and angiogenesis; used as a surface marker [5, 7] |
| CDH5 (VE-cadherin) | Endothelial-specific adhesion molecule | Marker of differentiated endothelial cells; required for barrier function [1, 7] |
| PECAM1 (CD31) | Endothelial cell adhesion molecule | Common marker for identifying endothelial cells in vitro and in vivo [3, 8] |
| NOTCH1 | Signaling receptor for arterial specification | Regulates arterial-venous identity; knockout alters endothelial differentiation [5, 7] |
| PROX1 | Transcription factor for lymphatic specification | Required for lymphatic endothelial differentiation [5, 7] |
| SOX18 | Transcription factor in lymphatic development | Cooperates with PROX1; mutations cause lymphatic defects [5, 7] |
| PIEZO1 | Mechanosensitive ion channel | Promotes vascular smooth muscle differentiation on large arteries |
| RUNX1 | Transcription factor in hemogenic endothelium | Essential for hematopoietic emergence from endothelium |
| COUP-TFII (NR2F2) | Transcription factor promoting venous identity | Suppresses arterial and lymphatic programs |
| HEY1/HEY2 | Notch target genes | Mediate arterial specification downstream of Notch |
| VEGFA | Secreted ligand for VEGFR2 | Drives endothelial differentiation and angiogenesis [5, 7] |
| BMP4 | Signaling ligand in mesodermal patterning | Promotes endothelial specification from mesoderm [5, 7] |
| TGFB1 | Signaling ligand modulating endothelial differentiation | Context-dependent effects on endothelial and smooth muscle programs [5, 7] |
How Is endothelial cell differentiation Regulated?
Endothelial cell differentiation is regulated by a combination of transcriptional, signaling, and mechanical inputs. The core transcriptional network, including ETV2, FLI1, TAL1, LMO2, and GATA2, establishes and maintains endothelial identity [1, 7]. Extracellular signals such as VEGF-A, Notch, BMP/TGF-beta, and Wnt modulate the timing and direction of differentiation [5, 7]. Mechanical forces sensed by Piezo1 influence vessel maturation and smooth muscle differentiation, linking hemodynamic cues to endothelial fate. Additionally, endothelial cells can release mitochondrial DNA that affects neighboring immune cells, indicating that differentiated endothelial cells actively participate in regulatory crosstalk.
endothelial cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Arterial specification defects, cardiovascular disease | Knockout and point-mutation endothelial cell lines [5, 7] |
| PROX1 | Lymphatic malformations | Knockout and overexpression in lymphatic endothelial cells [5, 7] |
| SOX18 | Lymphatic and vascular anomalies | Knock-in of patient mutations in iPSC-derived endothelial cells [5, 7] |
| PIEZO1 | Vascular remodeling and mechanotransduction disorders | Knockout and point-mutation in endothelial cells under shear stress |
| VEGFA | Tumor angiogenesis, ischemic disease | Overexpression and knockout in endothelial differentiation models [5, 7] |
Cardiovascular disease and vascular malformations
Defects in endothelial cell differentiation contribute to cardiovascular diseases, including impaired angiogenesis, atherosclerosis, and vascular malformations [5, 7]. Mutations in genes such as NOTCH1, PROX1, and SOX18 disrupt arterial-venous or lymphatic specification, leading to vascular anomalies [5, 7]. Targeting endothelial differentiation pathways is therefore a therapeutic strategy for promoting or inhibiting vessel growth in ischemic and oncologic settings.
Cancer and tumor angiogenesis
Tumor growth depends on angiogenesis, a process that recruits and differentiates endothelial cells to form new blood vessels [5, 7]. Dysregulated endothelial differentiation can produce aberrant, leaky vessels that support tumor progression. Anti-angiogenic therapies aim to block VEGF signaling and other pathways that drive endothelial differentiation within tumors [5, 7].
Infectious and inflammatory conditions
Endothelial cells interact with immune cells during infection and inflammation. For example, endothelial cell-released mitochondrial DNA promotes B cell differentiation and virus replication during severe fever with thrombocytopenia syndrome virus infection. In the liver, endothelial cells and stellate cells imprint Kupffer cell identity on colonizing monocytes, highlighting the role of endothelial differentiation in organ-specific immunity.
From endothelial cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is ETV2 required for endothelial differentiation? | CRISPR knockout in hPSC-derived endothelial cells [1, 7] |
| Does a specific NOTCH1 point mutation alter arterial specification? | Point-mutation knock-in in endothelial cell lines [5, 7] |
| Can a disease-associated SOX18 variant impair lymphatic differentiation? | Knock-in of the variant in iPSC-derived lymphatic endothelial cells [5, 7] |
| What is the effect of PIEZO1 overexpression on vessel maturation? | Overexpression in endothelial cells under shear stress |
| Can a tagged endothelial marker be used for live imaging? | Tagged knock-in of CDH5 or PECAM1 in hPSCs [3, 8] |
| Which genes regulate hemogenic endothelium formation? | CRISPR library screening in differentiating hPSCs |
How to Study the endothelial cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identifying endothelial differentiation trajectories [1, 3] |
| Single-cell RNA-seq | Cell-to-cell heterogeneity | Characterizing hemogenic endothelium and endothelial subsets |
| Proteomics | Protein abundance and modifications | Quantifying endothelial markers and signaling proteins [1, 7] |
| Tube formation assay | Angiogenic capacity | Functional validation of differentiated endothelial cells [3, 8] |
| Acetylated LDL uptake | Endothelial scavenger function | Confirming endothelial identity in vitro [3, 8] |
| Immunofluorescence | Protein localization and marker expression | Visualizing endothelial monolayers and vessels [3, 8] |
| Flow cytometry | Surface marker expression | Isolating CD31+ or VEGFR2+ endothelial cells [3, 8] |
| CRISPR screening | Gene function at scale | Discovering regulators of endothelial differentiation [1, 5] |
Transcriptomic profiling of differentiation
RNA-seq and single-cell RNA-seq are widely used to track the expression of endothelial markers and transcription factors during differentiation [1, 3]. These methods can identify novel regulators and verify the acquisition of endothelial identity in vitro [3, 8].
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify endothelial surface markers and signaling intermediates during differentiation [1, 7]. Phosphoproteomics reveals activation states of VEGF, Notch, and other pathways [5, 7].
Functional assays for endothelial identity
Tube formation assays, acetylated LDL uptake, and barrier function tests are used to confirm endothelial differentiation [3, 8]. These assays complement marker-based characterization.
Imaging and lineage tracing
Live imaging of fluorescently tagged endothelial markers, such as CDH5 or PECAM1, allows real-time monitoring of differentiation in vitro and in vivo [3, 8]. Lineage tracing in model organisms can reveal the origin of endothelial cells [1, 7].
How CRISPR Can Be Used to Study GO:0045446 endothelial cell differentiation
Knockout
CRISPR knockout of endothelial differentiation genes such as ETV2, FLI1, or NOTCH1 can reveal their requirement for endothelial specification and vessel formation [1, 5, 7]. Knockout hPSC lines differentiated into endothelial cells provide a controlled system to study loss-of-function phenotypes [1, 3].
Point Mutation
Point mutations identified in patients with vascular anomalies can be introduced into endothelial cells using CRISPR base editing or homology-directed repair [5, 7]. These models help determine whether a specific variant is causal for altered endothelial differentiation.
Knock-in
Knock-in of fluorescent reporters or epitope tags at endogenous endothelial loci, such as CDH5 or PECAM1, enables live tracking of differentiation and isolation of pure endothelial populations [3, 8]. Knock-in of disease variants can also model genetic vascular disorders [5, 7].
Overexpression
CRISPR activation or lentiviral overexpression can drive expression of pro-endothelial factors like ETV2 or VEGFA to enhance endothelial differentiation from stem cells [1, 5, 7]. Overexpression models are useful for gain-of-function studies and for producing endothelial cells at scale [3, 8].
How EDITGENE Supports endothelial cell differentiation Research
Researchers studying endothelial cell differentiation-related genes often need to determine whether a candidate gene is causally involved in endothelial specification, maturation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for endothelial cell differentiation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ACVR1 Knockout HEK293 Cell Line | EDJ-KQ361 | Human | 90 | Details Get a Quote |
| FBN1 Knockout HEK293 Cell Line | EDJ-KQ376 | Human | 2200 | Details Get a Quote |
| JAG1 Knockout HEK293 Cell Line | EDJ-KQ427 | Human | 182 | Details Get a Quote |
| NOTCH4 Knockout HEK293 Cell Line | EDJ-KQ439 | Human | 4855 | Details Get a Quote |
| S1PR1 Knockout HEK293 Cell Line | EDJ-KQ1008 | Human | 1901 | Details Get a Quote |
| FSTL1 Knockout HEK293 Cell Line | EDJ-KQ3736 | Human | 11167 | Details Get a Quote |
| SCUBE1 Knockout HEK293 Cell Line | EDJ-KQ9510 | Human | 80274 | Details Get a Quote |
| KDM6B Knockout HEK293 Cell Line | EDJ-KQ13919 | Human | 23135 | Details Get a Quote |
| MESP1 Knockout HEK293 Cell Line | EDJ-KQ14237 | Human | 55897 | Details Get a Quote |
| SETSIP Knockout HEK293 Cell Line | EDJ-KQ15237 | Human | 646817 | Details Get a Quote |
| KDR Knockout HEK293 Cell Line | EDJ-KQ17675 | Human | 3791 | Details Get a Quote |
| ACVRL1 Knockout HEK293 Cell Line | EDJ-KQ17795 | Human | 94 | Details Get a Quote |
| FBN1 Knockout HeLa Cell Line | EDJ-KQ17981 | Human | 2200 | Details Get a Quote |
| JAG1 Knockout A-549 Cell Line | EDJ-KQ17998 | Human | 182 | Details Get a Quote |
| S1PR1 Knockout HeLa Cell Line | EDJ-KQ20063 | Human | 1901 | Details Get a Quote |
Displaying Records 1 To 15 Of 59 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About endothelial cell differentiation
What is GO:0045446 endothelial cell differentiation?
GO:0045446 is the biological process in which a mesodermal, bone marrow, or neural crest cell acquires the specialized features of an endothelial cell, a thin flattened cell that lines body cavities, blood vessels, and lymph vessels [1, 7].
What genes are involved in endothelial cell differentiation?
Key genes include ETV2, FLI1, TAL1, LMO2, GATA2, KDR, CDH5, PECAM1, NOTCH1, PROX1, SOX18, and PIEZO1, among others [1, 4, 5, 7].
How is endothelial cell differentiation regulated?
It is regulated by a core transcriptional network (ETV2, FLI1, TAL1, LMO2, GATA2) and signaling pathways such as VEGF-A, Notch, BMP/TGF-beta, and mechanotransduction via Piezo1 [1, 4, 5, 7].
What diseases are associated with defective endothelial cell differentiation?
Defects are linked to cardiovascular diseases, vascular malformations, tumor angiogenesis, and certain infectious/inflammatory conditions [2, 5, 6, 7].
How can I study endothelial cell differentiation in the lab?
Common methods include hPSC/iPSC differentiation, RNA-seq, proteomics, tube formation assays, and CRISPR knockout or knock-in models [1, 3, 5, 8].
What is the role of ETV2 in endothelial differentiation?
ETV2 is a master transcriptional regulator that initiates the endothelial program and is required for endothelial and hematopoietic lineage specification [1, 7].
Can endothelial cells be generated from induced pluripotent stem cells?
Yes, iPSCs can be differentiated into endothelial cells, including brain microvascular endothelial cells, for in vitro applications [3, 8].
What is hemogenic endothelium?
Hemogenic endothelium is a specialized endothelial intermediate that gives rise to hematopoietic cells while retaining endothelial potential.
How does Piezo1 influence endothelial differentiation?
Piezo1 is a mechanosensitive channel that promotes vascular smooth muscle cell differentiation on large arteries, linking blood flow forces to vessel maturation.
What CRISPR models are available for endothelial differentiation research?
Knockout, point mutation, knock-in, tagged knock-in, and overexpression models can be generated in endothelial or stem cell backgrounds to study gene function [1, 3, 5, 7].
Conclusion
GO:0045446 endothelial cell differentiation is a fundamental developmental process that builds the vascular system and supports organ function. Its regulation by a conserved transcriptional network and diverse signaling inputs makes it a rich area for both basic and translational research [1, 5, 7]. Dysregulation of this process contributes to cardiovascular disease, cancer, and immune disorders, underscoring the need for precise experimental models [2, 5, 6]. CRISPR-based approaches, combined with stem cell differentiation and multi-omics profiling, offer powerful tools to dissect the mechanisms and therapeutic potential of endothelial cell differentiation [1, 3, 8].
References
- 1. Aragon JW et al.. 2022. Endothelial Cell Differentiation and Hemogenic Specification.. Cold Spring Harb Perspect Med 12(7) PMID: 35193895
- 2. Bonnardel J et al.. 2019. Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche.. Immunity 51(4):638-654.e9 PMID: 31561945
- 3. Medina A et al.. 2022. iPS Cell Differentiation into Brain Microvascular Endothelial Cells.. Methods Mol Biol 2429:201-213 PMID: 35507163
- 4. Abello J et al.. 2025. Endothelial cell Piezo1 promotes vascular smooth muscle cell differentiation on large arteries.. Eur J Cell Biol 104(1):151473 PMID: 39729736
- 5. Guo Z et al.. 2021. Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases.. Life Sci 276:119406 PMID: 33785330
- 6. Zhang Y-F et al.. 2025. Endothelial cell-released mitochondrial DNA promotes B cell differentiation and virus replication during severe fever with thrombocytopenia syndrome virus infection.. J Virol 99(6):e0132324 PMID: 40366175
- 7. Marcelo KL et al.. 2013. Regulation of endothelial cell differentiation and specification.. Circ Res 112(9):1272-87 PMID: 23620236
- 8. Raniga K et al.. 2022. Differentiation and Characterization of Human Pluripotent Stem Cell-Derived Cardiac Endothelial Cells for In Vitro Applications.. Methods Mol Biol 2441:339-348 PMID: 35099750
